Altre lingue Jiangsu Nhwa Pharmaceutical Co., LTD

Azioni

002262

CNE100000CG8

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
23,97 ^CNY	+1,44%		+3,68%	-11,62%

19/04	Jiangsu Nhwa Pharmaceutical Co., LTD riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
03/04	Nhwa Pharma ottiene l'autorizzazione a testare le compresse di ossalato NH103	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	03/04
Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Profit Distribution for 2023	01/04
Nhwa Pharmaceutical's 2023 Profit Climbs 15% as Revenue Rises 17%	01/04
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO in China	27/02
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week	26/02
Teva Pharmaceutical Investments Singapore Pte Ltd. and Jiangsu Nhwa Pharmaceutical Co., LTD Forge Strategic Partnership to Promote Patient Access to Austedo® in China	26/02
Nhwa Pharmaceutical Gets Green Light from US FDA After Addressing API Deficiencies	21/12
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Beijing Yihua M-Health Technology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Jiangsu Nhwa Pharmaceutical Co., LTD	25/10/23
Jiangsu Nhwa Pharmaceutical Co., LTD(XSEC:002262) added to FTSE All-World Index	18/09/23
Jiangsu Nhwa Pharma’s H1 Profit Jumps 21.7% as Revenue Rises 20%	31/07/23
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	30/07/23
Wang Zeyu cancelled the acquisition of 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD.	28/07/23
Expected House Vote on Debt Ceiling Deal Weighs on Sentiment, Pushing US Equity Futures Lower	31/05/23
Trevena Receives $3 Million Milestone Payment From Partner Jiangsu Nhwa Pharmaceutical	31/05/23
Top Premarket Gainers	31/05/23
Jiangsu Nhwa Pharmaceutical Co., Ltd. Receives Formal Approval from the National Medical Products Administration for OLINVYK	08/05/23
Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2022, Payable on 28 April 2023	17/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jiangsu Nhwa Pharmaceutical Co., LTD

Azioni

002262

CNE100000CG8

Altre lingue

Filtri